The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibody Therapeutics and Blood Antibody Therapeutics Market Insights and Forecast to 2028
Synopsis
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
Market Analysis and Insights: Global Antibody Therapeutics and Blood Antibody Therapeutics Market
The global Antibody Therapeutics and Blood Antibody Therapeutics market size is projected to reach US$ 373470 million by 2028, from US$ 191410 million in 2021, at a CAGR of 9.9% during 2022-2028.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibody Therapeutics and Blood Antibody Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibody Therapeutics and Blood Antibody Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibody Therapeutics and Blood Antibody Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibody Therapeutics and Blood Antibody Therapeutics market.
Global Antibody Therapeutics and Blood Antibody Therapeutics Scope and Market Size
Antibody Therapeutics and Blood Antibody Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antibody Therapeutics and Blood Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
Market Analysis and Insights: Global Antibody Therapeutics and Blood Antibody Therapeutics Market
The global Antibody Therapeutics and Blood Antibody Therapeutics market size is projected to reach US$ 373470 million by 2028, from US$ 191410 million in 2021, at a CAGR of 9.9% during 2022-2028.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibody Therapeutics and Blood Antibody Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibody Therapeutics and Blood Antibody Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibody Therapeutics and Blood Antibody Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibody Therapeutics and Blood Antibody Therapeutics market.
Global Antibody Therapeutics and Blood Antibody Therapeutics Scope and Market Size
Antibody Therapeutics and Blood Antibody Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antibody Therapeutics and Blood Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2017-2028)
2.2 Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Region
2.2.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue
3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2021
3.5 Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2023-2028)
5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application
5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
6.2.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
6.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
6.4.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
7.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
7.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
7.4.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
8.2.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
8.3.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region
8.4.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
9.2.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
9.3.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
9.4.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type
10.2.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application
10.3.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
10.4.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.2.5 Abbvie Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.3.5 Johnson & Johnson Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.7.5 Alexion Pharmaceuticals Recent Developments
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.8.5 Takeda Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.9.5 Amgen Recent Developments
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.10.5 Biogen Recent Developments
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.11.5 UCB Recent Developments
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.12.5 Eli Lilly and Company Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
11.13.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of IgG1
Table 3. Key Players of IgG4
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2017-2022)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2023-2028)
Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2021)
Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service
Table 22. Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Roche Recent Developments
Table 67. Abbvie Company Details
Table 68. Abbvie Business Overview
Table 69. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Abbvie Recent Developments
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Recent Developments
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Developments
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Novartis Recent Developments
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Merck Recent Developments
Table 92. Alexion Pharmaceuticals Company Details
Table 93. Alexion Pharmaceuticals Business Overview
Table 94. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Alexion Pharmaceuticals Recent Developments
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 101. Takeda Recent Developments
Table 102. Amgen Company Details
Table 103. Amgen Business Overview
Table 104. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Amgen Recent Developments
Table 107. Biogen Company Details
Table 108. Biogen Business Overview
Table 109. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Biogen Recent Developments
Table 112. UCB Company Details
Table 113. UCB Business Overview
Table 114. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 115. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 116. UCB Recent Developments
Table 117. Eli Lilly and Company Company Details
Table 118. Eli Lilly and Company Business Overview
Table 119. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 120. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 121. Eli Lilly and Company Recent Developments
Table 122. AstraZeneca Company Details
Table 123. AstraZeneca Business Overview
Table 124. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 125. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 126. AstraZeneca Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. IgG1 Features
Figure 3. IgG4 Features
Figure 4. Others Features
Figure 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Autoimmune Case Studies
Figure 7. Tumor Case Studies
Figure 8. Others Case Studies
Figure 9. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2021
Figure 14. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2021
Figure 16. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
Figure 18. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
Figure 20. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
Figure 26. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Region (2017-2028)
Figure 36. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
Figure 46. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 56. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 57. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 61. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 62. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 63. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 64. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 65. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 67. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
